Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation.

  • Authors : Lin M; State Key Laboratory for Diagnosis and Treatment of Infectious Disease, and National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, China.; Life Sciences Institute, Zhejiang University, Hangzhou, 310058, Zhejiang, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology

  • Source: Nature communications [Nat Commun] 2024 Jun 11; Vol. 15 (1), pp. 4995. Date of Electronic Publication: 2024 Jun 11.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1/miR-195-5p axis-dependent manner in hepatocellular carcinoma.

  • Authors : Li J; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.; Li Y

Subjects: Sorafenib*/Sorafenib*/Sorafenib*/pharmacology ; Sorafenib*/Sorafenib*/Sorafenib*/therapeutic use ; Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 May 14; Vol. 43 (1), pp. 143. Date of Electronic Publication: 2024 May 14.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

×
Academic Journal

Stress-induced epinephrine promotes hepatocellular carcinoma progression via the USP10-PLAGL2 signaling loop.

  • Authors : Wang C; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 211198, PR China.; Ni J

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/etiology

  • Source: Experimental & molecular medicine [Exp Mol Med] 2024 May; Vol. 56 (5), pp. 1150-1163. Date of Electronic Publication: 2024 May 01.Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9607880 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.

  • Authors : Liang J; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China.; Yao N

Subjects: beta Catenin*/beta Catenin*/beta Catenin*/metabolism ; beta Catenin*/beta Catenin*/beta Catenin*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics

  • Source: Journal of cellular physiology [J Cell Physiol] 2024 May; Vol. 239 (5), pp. e31237. Date of Electronic Publication: 2024 Mar 11.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0050222 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

GPX4 transcriptionally promotes liver cancer metastasis via GRHL3/PTEN/PI3K/AKT axis.

  • Authors : Pan R; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200217, China.; Zhao Z

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/metabolism ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/genetics ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology

  • Source: Translational research : the journal of laboratory and clinical medicine [Transl Res] 2024 Sep; Vol. 271, pp. 79-92. Date of Electronic Publication: 2024 May 24.Publisher: Elsevier Country of Publication: United States NLM ID: 101280339 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma.

  • Authors : Yin YT; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Shi L

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; DNA-Binding Proteins*/DNA-Binding Proteins*/DNA-Binding Proteins*/metabolism ; Janus Kinase 2*

  • Source: Medical oncology (Northwood, London, England) [Med Oncol] 2024 Feb 23; Vol. 41 (3), pp. 79. Date of Electronic Publication: 2024 Feb 23.Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X

Record details

×
Academic Journal

ZBTB7B is a permissive regulator of hepatocellular carcinoma initiation by repressing c-Jun expression and function.

  • Authors : Zhu Y; State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.; Wang Q

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; DNA-Binding Proteins*/DNA-Binding Proteins*/DNA-Binding Proteins*/genetics ; DNA-Binding Proteins*/DNA-Binding Proteins*/DNA-Binding Proteins*/metabolism

  • Source: Cell death & disease [Cell Death Dis] 2024 Jan 15; Vol. 15 (1), pp. 55. Date of Electronic Publication: 2024 Jan 15.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

BORIS variant SF2(C2/A4) promotes the malignant development of liver cancer by activating epithelial-mesenchymal transition and hepatic stellate cells.

  • Authors : Wei L; Department of Biochemistry and Molecular Biology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan Province, China.; Liu Z

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology ; DNA-Binding Proteins*/DNA-Binding Proteins*/DNA-Binding Proteins*/genetics

  • Source: Molecular carcinogenesis [Mol Carcinog] 2023 Jun; Vol. 62 (6), pp. 731-742. Date of Electronic Publication: 2023 Mar 17.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Role of SET oncoprotein in hepatocellular carcinoma: An immunohistochemical study.

  • Authors : Gadallah M; Faculty of Medicine, Pathology, Menoufia University, Shebin El-Kom, Egypt.; Asaad NY

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; DNA-Binding Proteins*/DNA-Binding Proteins*/DNA-Binding Proteins*/genetics

  • Source: Journal of immunoassay & immunochemistry [J Immunoassay Immunochem] 2022 Jul 04; Vol. 43 (4), pp. 420-434. Date of Electronic Publication: 2022 Feb 13.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100963688 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET.

  • Authors : Zhang T; Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei Province, China.; Wang Y

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; DNA-Binding Proteins*/DNA-Binding Proteins*/DNA-Binding Proteins*/genetics ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Sep 16; Vol. 41 (1), pp. 275. Date of Electronic Publication: 2022 Sep 16.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

×
  • 1-10 of  893 results for ""Carcinoma, Hepatocellular""